NASDAQ:AVDL
Avadel Pharmaceuticals plc Stock News
$18.82
+0.520 (+2.84%)
At Close: May 03, 2024
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2021 Financial Results on November 8th
08:00am, Monday, 01'st Nov 2021
DUBLIN, Ireland, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that it will host a confer
Avadel Pharmaceuticals: I Am Holding
09:00pm, Sunday, 31'st Oct 2021
Avadel Pharmaceuticals: I Am Holding
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avadel Pharmaceuticals plc - AVDL
07:02pm, Monday, 18'th Oct 2021
New York, New York--(Newsfile Corp. - October 18, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Avadel Pharmaceuticals plc ("Avadel" or the "Company") (NASDAQ: AVDL). Such
Why Shares of Avadel Are Sinking Today
02:12pm, Monday, 18'th Oct 2021
A key regulatory decision is overdue, leaving shareholders to wonder when it might arrive.
Avadel Pharmaceuticals Announces Ongoing FDA Review of NDA for FT218 for Patients with Narcolepsy
05:00pm, Friday, 15'th Oct 2021
DUBLIN, Ireland, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, announced today that the U.S. Food and Dru
Implied Volatility Surging for Avadel (AVDL) Stock Options
10:30am, Wednesday, 29'th Sep 2021
Investors need to pay close attention to Avadel (AVDL) stock based on the movements in the options market lately.
DUBLIN, Ireland, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for
Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q2 2021 Results - Earnings Call Transcript
12:39pm, Monday, 09'th Aug 2021
Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q2 2021 Results - Earnings Call Transcript
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results
08:00am, Monday, 09'th Aug 2021
DUBLIN, Ireland, Aug. 09, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for
Avadel Pharmaceuticals, The Jazz-Killer
07:33am, Thursday, 05'th Aug 2021
Avadel's once-nightly FT218 improves considerably over Xyrem's twice-nightly dosing.
Avadel Pharmaceuticals to Present at the Ladenburg Thalmann Annual Healthcare Conference 2021
08:00am, Wednesday, 07'th Jul 2021
DUBLIN, Ireland, July 07, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for
Healthcare And Biotech Stocks Face Important Decisions, Remain A Promising Investment
10:27am, Wednesday, 02'nd Jun 2021
Healthcare faces an important decision as the Supreme Court decides on the Affordable Care Act. Biotechs face an important FDA decision on approval of an Alzheimer's treatment.
Avadel Pharmaceuticals - A Compelling Buy
09:40am, Friday, 14'th May 2021
Avadel Pharmaceuticals - A Compelling Buy
Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q1 2021 Results - Earnings Call Transcript
01:22pm, Monday, 10'th May 2021
Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q1 2021 Results - Earnings Call Transcript
Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results
08:00am, Monday, 10'th May 2021
DUBLIN, Ireland, May 10, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate desi
